Is the generally accepted therapeutic benefit of exercise training in patients with peripheral arterial occlusive disease evidence based? Analysis of the Cochrane review;Ist der allgemein akzeptierte therapeutische nutzen des gehtrainings bei patienten mit arterieller verschlusskrankheit evidenzbasiert? Analyse des Cochrane-reviews

Hamostaseologie

Volumn 26, Issue 3, 2006, Pages 224-228

  Amendt, Klaus ^a,b  

^a Diakonie Krankenhaus Mannheim   (Germany)

^b Diakonie Krankenhaus Mannheim   (Germany)

Author keywords

Cochrane review; Evidence based medicine; Exercise training; Intermittent claudication

Indexed keywords

DIPYRIDAMOLE; PENTOXIFYLLINE; PLACEBO;

CLINICAL TRIAL; EVIDENCE BASED MEDICINE; EXERCISE; HEART SURGERY; HUMAN; INTERMITTENT CLAUDICATION; MEDICAL LITERATURE; META ANALYSIS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PUBLICATION; REVIEW; SYSTEMATIC REVIEW; TREADMILL EXERCISE; WALKING; FITNESS;

ARTERIAL OCCLUSIVE DISEASES; EVIDENCE-BASED MEDICINE; EXERCISE; HUMANS; PHYSICAL FITNESS;

EID: 33748413069     PISSN: 07209355     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1617070     Document Type: Review

References (31)

1. Arzneimittelkommission der Deutschen Ärzteschaft. Empfehlungen zur Therapie der peripheren arteriellen Verschlusskrankheit (pAVK). 3. Auflage. Arzneiverordnung in der Praxis, Band 31, Sonderheft 3 (Therapieempfehlungen), Juli 2004.
2. Buchwalsky R, Blümchen G. Kurz- und Langzeiteffekte körperlichen Trainings. In: Müller-Wiefel H, Barras JP, Ehringer H, Krüger M (eds). Mikrozirkulation und Blutrheologie-Therapie der arteriellen Verschlußkrankheit. Baden-Baden, Köln, New York: Witzstrock 1980; 150-4.
3. Cachovan M, Scheffler P, Gruss J et al. The effectiveness of standardized exercise training in intermittent claudication. Wien Klin Wochenschr 1994; 106: 517-20.
4. Ciuffetti G, Paltriccia R, Lombardini R et al. Treating peripheral arterial occlusive disease: pentoxifylline vs exercise. Int Angiol 1994; 13: 33-9.
5. Creasy TS, McMillan PJ, Fletcher EWL et al. Is percutaneous transluminal angioplasty better than exercise for claudication? - Preliminary results from a prospective randomised trial. Eur J Vasc Surg 1990; 4: 135-40.
6. Creutzig A, Diehm C, Heidrich H et al. Chronische periphere arterielle Verschlußkrankheit. In: Classen M, Dierkesmann R, Heimpel H et al (eds). Rationelle Diagnostik und Therapie in der Inneren Medizin. München: Urban & Fischer 2003.
7. Dahllöf AG, Bjorntorp P, Holm J et al. Metabolic activity of skeletal muscle in patients with peripheral arterial insufficiency; effect of physical training. Eur J Clin Invest 1974; 4: 9-15.
8. De La Haye R, Diehm C, Blume J et al. Eine epidemiologische Untersuchung zum Einsatz von Gefaßsport bei der arteriellen Verschlußkrankheit. Vasa 1991; Suppl 32: 416-9.
9. EMEA. The European Agency for the Evaluation of Medicinal Products. Committee for Proprietary Medicinal Products (CPMP). CPMP/EWP/714/98 rev 1. Note for guidance on clinical investigation of medicinal products for the treatment of peripheral arterial occlusive disease. London: 25 April 2002. http://www.emea.eu.int/pdfs/human/ewp/071498en.pdf
10. Gardner AW, Katzel LI, Sorkin JD et al. Exercise rehabilitation improves functional outcomes and peripheral circulation in patients with intermittent claudication: a randomized controlled trial. J Am Geriatr Soc 2001; 49: 755-62.
11. Gardner AW, Poehlman ET. Exercise rehabilitation programs for the treatment of claudication pain. JAMA 1995; 274: 975-80.
12. Gartenmann C, Kirchberger I, Herzig M et al. Effects of exercise training program on functional capacity and quality of life in patients with peripheral arterial occlusive disease. Evaluation of a pilot project. VASA 2002; 31: 29-34.
13. Gibellini R, Fanello M, Bardile AF et al. Exercise training in intermittent claudication. Int Angiol 2000; 19: 8-13.
14. Hiatt WR, Regensteiner JG, Hargarten ME et al. Benefit of exercise conditioning for patients with peripheral arterial disease. Circulation 1990; 81: 602-9.
15. Hiatt WR, Wolfel EE, Meier RH et al. Superiority of treadmill walking exercise versus strength training for patients with peripheral arterial disease. Circulation 1994; 90: 1866-74.
16. Hirsch AT, Haskal ZJ, Hertzer NR et al. ACC/AHA guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic). http://www.acc.org/clinical/guidelines/pad/ in dex.pdf.
17. Holm J, Dahllöf AG, Bjoratorp P et al. Enzyme studies in muscles of patients with intermittent claudication. Effect of training. Scand J Clin Lab Invest 1973; 31 (Suppl 128): 201-5.
18. Izquierdo-Porrera AM, Gardner AW, Powell CC et al. Effects of exercise rehabilitation on cardiovascular risk factors in older patients with peripheral arterial occlusive disease. J Vasc Surg 2000; 31: 670-7.
19. ICH E9. The European Agency for the Evaluation of Medicinal Products. ICH Topic E9. Statistical principles for clinical trials. CPMP/ICH/363/96. Note for guidance on statistical principles for clinical trials. London: 18 March 1998. http://www. emea.eu.int/pdfs/human/ich/036396en.pdf
20. Larsen OA, Lassen NA. Effect of daily muscle exercise in patients with intermittent claudication. Lancet 1966a; II: 1093-5.
21. Larsen OA, Lassen NA. Effect of daily muscular exercise in patients with intermittent claudication. Scand J Clin Lab Invest 1966b; Suppl 93: 168-71.
22. Leng GC, Fowler B, Ernst E. Exercise for intermittent claudication. The Cochrane Library 2004, Issue 4. Chichester, UK: John Wiley & Sons Ltd.
23. Lundgren F, Dahllöf AG, Byland-Fellenius AC. Muscle enzyme adaptation in patients with peripheral arterial insufficiency: spontaneous adaptation, effect of different treatments and consequences on walking performance. Clin Sci 1989; 77: 485-93.
24. Lundgren F, Dahllöf AG, Lundholm K et al. Intermittent claudication - surgical reconstruction or physical training? A prospective randomised trial of treatment efficiency. Ann Surg 1989; 209: 346-55.
25. Mannarino E, Pasqualini L, Innocente S et al. Physical training and antiplatelet treatment in stage II peripheral arterial occlusive disease: alone or combined? Angiology 1991; 42: 513-21.
26. Reiter M, Bucek RA, Stümpflen A et al. Prostanoids for intermittent claudication. The Cochrane Library 2004, Issue 4. Chichester, UK: John Wiley & Sons.
27. Robeer GG, Brandsma JW, van den Heuvel SP et al. Exercise therapy for intermittent claudication: A review of the quality of randomised clinical trials and evaluation of predictive factors. Eur J Vasc Endovasc Surg 1998; 15: 36-43.
28. TASC Working Group. Management of peripheral arterial disease (PAD). TransAtlantic Inter-Society Consensus (TASC). Int Angiol 2000; 19 (1 Suppl 1): IXXIV, 1-304.
29. Tisi PV, Hulse M, Chulakadabba A et al. Exercise training for intermittent claudication: does it adversly affect biochemical markers of the exercise-induced inflammatory response? Eur J Vasc Endovasc Surg 1997; 14: 344-50.
30. Tsai JC, Chan P, Wang CH et al. The effects of exercise training on walking function and perception of health status in elderly patients with peripheral arterial occlusive disease. J Intern Med 2002; 252: 448-55.
31. Weidinger P. Langzeitergebnisse eines arteriellen Gefäß trainings bei obliterierender Arteriopathie - 4 Jahresstudie. In: Häring H (ed). Berichtsband. 5. Gemeinsame Jahrestagung der Angiologischen Gesellschaften der Bundesrepublik Deutschland, Österreichs und der Schweiz. Gräfelfing: Demeter 1985; 343-5.